Grading von Lungenkarzinomen

Bohle RM, Kim YJ, Schnabel PA (2015) Lungentumoren – Lehrserie Nr. 221, Internationale Akademie für Pathologie, Deutsche Abteilung e. V.

Collisson EA, Campbell JD, Brooks AN et al (2014) Comprehensive molecular profiling of lung adenocarcinoma. cancer genome atlas research network. Nature 511:543–540

Kadota K, Colovos C, Suzuki K et al (2012) FDG-Pet SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma. Ann Surg Oncol 19:3598–3605

Kadota K, Suzuki K, Kachala SS et al (2012) A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma. Mod Pathol 25:1117–1127

Kadota K, Nitadori J, Woo KM et al (2014) Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes. J Thorac Oncol 9:1126–1139

Kadota K, Yeh Y‑C, D’Angelo S et al (2014) Association between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation. Am J Surg Pathol 38:1118–1127

Moreira AL, Joubert P, Downey RJ et al (2014) Cribriform and fused glands are patterns of high-grade pulmonary adenocarcinoma. Hum Pathol 45:213–220

Nakazato Y, Maeshima AM, Ishikawa Y et al (2013) Interobserver agreement in the nuclear grading of primary pulmonary adenocarcinoma. J Thorac Oncol 8:736–734

Nitadori JI, Bograd AJ, Kadota K et al (2013) Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2 cm or smaller. J Natl Cancer Inst 105:1212–1220

Petersen I (2013) Adenokarzinome der Lunge – die neue Klassifikation. Zentralbl Chir 138:S16–S24

Rao N, Moran C, Suster S (2013) Tumors of the Lungs and Pleura. In: Damjanov I, Fen F (Hrsg) Cancer Grading Manual. Springer, Berlin Heidelberg, S 31

Saeger W, Schnabel PA, Komminoth P (2016) Grading neuroendokriner Tumoren. Pathologe. doi:10.1007/s00292-016-0186-4

Sasada S, Nakayama H, Miyata Y et al (2015) Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinoma. Ann Thorac Surg 99:956–960

Seidel D, Zander T, Heukamp LC et al (2013) A genomics-based classification of human lung tumors – Clinical Lung Cancer Genome Project (CLCGP); Network Genomic Medicine (NGM). Sci Transl Med 5(209):209ra153

Sigel CS, Rudomina DE, Sima CS et al (2012) Predicting pulmonary adenocarcinoma outcome based on a cytology grading system. Cancer Cytopathol 128:35–43

Travis WD, Brambilla E, Müller-Hermelink HK et al (2004) Tumors of the lung, pleura thymus and heart. In: World Health Organization classification of tumors. Pathology and genetics. IARC Press, Lyon

Travis WD, Brambilla E, Burke AP et al (2015) WHO Classification of tumors of the lung, pleura, thymus and heart. IARC Press, Lyon

Travis WD, Brambilla E, Noguchi M et al (2011) International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244–285

Travis WD, Brabilla E, Geisinger KR (2016) Histological grading in lung cancer: one system for all or separate systems for each histological type? Eur Respir J 47:720–723

Thunissen E, Kerr KM, Herth FJF et al (2012) The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group. Lung Cancer 76:1–18

Von der Thüsen JH, Tham YS, Pattenden H et al (2013) Prognostic significance of predominant histologic pattern and nuclear grade in resected adenocarcinoma of the lung: potential parameters for a grading system. J Thorac Oncol 8:37–44

Warth A, Muley T, Meister M et al (2012) The novel histologic international association for the study of lung cancer/american thoracic society/european respiratory society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 30:1438–1446

Warth A, Stenzinger A, Brünneck AC von et al (2012) Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas. Eur Respir J 40:1221–1227

Warth A, Cortis C, Soltermann A et al (2014) Tumor cell proliferation (Ki-67) in non-small cell lung cancer: a critical reapprisal of its prognostic role. Br J Cancer 111:1222–1229

Warth A, Penzel R, Lindenmaier H et al (2014) EGFR, KRAS, and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunotype. Eur Respir J 43:872–883

Warth A, Muley T, Kossakowski C et al (2015) Prognostic impact and clinicopathological correlations of the cribriform pattern in pulmonary adenocarcinoma. J Thorac Oncol 10:638–644

Weichert W, Kossakowski C, Harms A et al (2016) Proposal of a prognostic relevant grading scheme for pulmonary squamous cell carcinoma. Eur Respir J 47:938–946

Westaway DD, Toon CW, Farzin M et al (2013) The international association for the study of lung cancer/american thoracic society/european respiratory society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma. Pathology 45:553–558

Zhao Z‑R, Xi S‑Y, Li W et al (2015) Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma. Lung Cancer 90:604–609